Report cover image

A Hospital Acquired Infection Control Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade

Publisher Fairfield Market Research
Published Jun 27, 2025
Length 225 Pages
SKU # FCSL20142625

Description

The global hospital acquired infection (HAI) control market is poised for consistent growth, fueled by increasing awareness of hygiene practices and the rising incidence of hospital-acquired infections. As per the latest insights by Fairfield Market Research, the market is projected to rise from USD 7.3 billion in 2025 to USD 9.7 billion by 2032, reflecting a steady CAGR of 4.14% during the forecast period. This growth is driven by heightened focus on patient safety, improved healthcare infrastructure, and technological advancements in sterilization and disinfection systems.

Market Insights

Over the past decade, the healthcare sector has experienced substantial shifts due to the integration of advanced medical technologies and a greater emphasis on infection prevention. With an increasing number of surgical procedures and the growing burden of chronic diseases, hospitals are under pressure to maintain high standards of cleanliness and infection control.

Disinfection equipment, in particular, is gaining prominence due to its vital role in preventing the spread of infections in medical settings. Public health campaigns and global health emergencies, such as the COVID-19 pandemic, have further accelerated the demand for effective infection control measures across hospitals, clinics, and diagnostic centers.

Market Drivers

Several key factors are contributing to the growth of the hospital acquired infection control market:
• Rising Number of Surgeries: Increased surgical volumes globally have elevated the need for reliable sterilization and disinfection equipment.
• Government Regulations: National health agencies are implementing strict guidelines for infection control in healthcare environments.
• Awareness Campaigns: Efforts by global organizations like WHO to promote hand hygiene and equipment sterilization are positively influencing market trends.
• Technological Innovation: The launch of cloud-connected, UV-based, and automated disinfection solutions is transforming infection control practices.

Business Opportunity

The demand for infection control solutions is expanding beyond hospitals to include ambulatory surgical centers, outpatient clinics, and diagnostic labs. This shift presents significant opportunities for manufacturers to introduce compact, portable, and cost-effective products that cater to a wider healthcare audience.

The increasing preference for minimally invasive surgeries and outpatient care is also opening new revenue streams for players in the market. As healthcare systems worldwide focus on improving infection control protocols, suppliers offering scalable and tech-enabled solutions are likely to witness higher adoption rates.

Regional Outlook
• United States: With advanced healthcare systems and widespread awareness, the U.S. continues to be a leading market for infection control products. A large number of surgical procedures and high healthcare spending further support market expansion.
• China: The country is emerging as a strong growth hub due to a rising number of HAIs, increasing awareness, and support from government health programs.
• India: Rapid developments in healthcare infrastructure and a growing focus on hygiene make India an attractive market for suppliers.
• Europe: The region maintains steady demand, with strong infection control policies and high adoption of sterilization equipment in hospitals.

Key Players

The competitive Analysis remains highly fragmented with a large number of players introducing innovative products and expanding their global footprint. Strategic acquisitions and R&D investments are key focus areas.

Notable developments include:
• PURioLABS introduced a portable cabinet that rapidly disinfects frequently used medical tools.
• Unimech Healthcare launched its UniClean series with UVGI and cloud-enabled features.
• STERIS plc acquired Cantel Medical to expand its infection prevention portfolio.
• UVision360 Inc. received regulatory approval to extend reprocessing capabilities for its LUMINELLE system.

Leading companies in the market include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc.

Market Segmentation

By Product
• Heat Sterilization Equipment
Moist Heat Sterilization
Dry Heat Sterilization
• Low-Temperature Sterilization Equipment
• Radiation Sterilization Equipment
• Disinfection Equipment
Disinfector
Washer Disinfector
Flusher Disinfector
Endoscopic Reprocessor Systems
Single Basin
Dual Basin
Disinfectants

By End User
• Hospitals
• Ambulatory Surgical Centres
• Medical Institutions
• Diagnostic Laboratories
• Clinics

By Region
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Please note: Delivery Timelines - 5 working days.

Table of Contents

225 Pages
1. Executive Summary
1.1. Global Hospital Acquired Infection Control Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Hospital Acquired Infection Control Market Outlook, 2019-2032
3.1. Global Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Heat Sterilization Equipment
3.1.1.1.1. Moist Heat Sterilization Equipment
3.1.1.1.2. Dry Heat Sterilization Equipment
3.1.1.2. Low-Temperature Sterilization Equipment
3.1.1.3. Radiation Sterilization Equipment
3.1.1.4. Disinfection Equipment
3.1.1.4.1. Disinfector
3.1.1.4.1.1. Disinfector
3.1.1.4.1.1.1. Washer Disinfector
3.1.1.4.1.1.2. Flusher Disinfector
3.1.1.4.2. Flusher Disinfector
3.1.1.5. Endoscopic Reprocessor Systems
3.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
3.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
3.1.1.6. Disinfectants
3.2. Global Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Ambulatory Surgical Centres
3.2.1.3. Medical Institutions
3.2.1.4. Diagnostic Laboratories
3.2.1.5. Clinics
3.3. Global Hospital Acquired Infection Control Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Hospital Acquired Infection Control Market Outlook, 2019-2032
4.1. North America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Heat Sterilization Equipment
4.1.1.1.1. Moist Heat Sterilization Equipment
4.1.1.1.2. Dry Heat Sterilization Equipment
4.1.1.2. Low-Temperature Sterilization Equipment
4.1.1.3. Radiation Sterilization Equipment
4.1.1.4. Disinfection Equipment
4.1.1.4.1. Disinfector
4.1.1.4.1.1. Disinfector
4.1.1.4.1.1.1. Washer Disinfector
4.1.1.4.1.1.2. Flusher Disinfector
4.1.1.4.2. Flusher Disinfector
4.1.1.5. Endoscopic Reprocessor Systems
4.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
4.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
4.1.1.6. Disinfectants
4.2. North America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Ambulatory Surgical Centres
4.2.1.3. Medical Institutions
4.2.1.4. Diagnostic Laboratories
4.2.1.5. Clinics
4.3. North America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1. Key Highlights
4.3.1.1. U.S. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1.2. U.S. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1.3. Canada Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.1.4. Canada Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Hospital Acquired Infection Control Market Outlook, 2019-2032
5.1. Europe Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Heat Sterilization Equipment
5.1.1.1.1. Moist Heat Sterilization Equipment
5.1.1.1.2. Dry Heat Sterilization Equipment
5.1.1.2. Low-Temperature Sterilization Equipment
5.1.1.3. Radiation Sterilization Equipment
5.1.1.4. Disinfection Equipment
5.1.1.4.1. Disinfector
5.1.1.4.1.1. Disinfector
5.1.1.4.1.1.1. Washer Disinfector
5.1.1.4.1.1.2. Flusher Disinfector
5.1.1.4.2. Flusher Disinfector
5.1.1.5. Endoscopic Reprocessor Systems
5.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
5.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
5.1.1.6. Disinfectants
5.2. Europe Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Ambulatory Surgical Centres
5.2.1.3. Medical Institutions
5.2.1.4. Diagnostic Laboratories
5.2.1.5. Clinics
5.3. Europe Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Germany Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.2. Germany Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.3. U.K. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.4. U.K. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.5. France Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.6. France Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.7. Italy Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.8. Italy Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.9. Turkey Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.10. Turkey Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.11. Russia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.12. Russia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.13. Rest of Europe Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.1.14. Rest of Europe Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Hospital Acquired Infection Control Market Outlook, 2019-2032
6.1. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Heat Sterilization Equipment
6.1.1.1.1. Moist Heat Sterilization Equipment
6.1.1.1.2. Dry Heat Sterilization Equipment
6.1.1.2. Low-Temperature Sterilization Equipment
6.1.1.3. Radiation Sterilization Equipment
6.1.1.4. Disinfection Equipment
6.1.1.4.1. Disinfector
6.1.1.4.1.1. Disinfector
6.1.1.4.1.1.1. Washer Disinfector
6.1.1.4.1.1.2. Flusher Disinfector
6.1.1.4.2. Flusher Disinfector
6.1.1.5. Endoscopic Reprocessor Systems
6.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
6.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
6.1.1.6. Disinfectants
6.2. Asia Pacific Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Ambulatory Surgical Centres
6.2.1.3. Medical Institutions
6.2.1.4. Diagnostic Laboratories
6.2.1.5. Clinics
6.3. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. China Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.2. China Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.3. Japan Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.4. Japan Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.5. South Korea Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.6. South Korea Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.7. India Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.8. India Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.9. Southeast Asia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.10. Southeast Asia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.11. Rest of Asia Pacific Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.1.12. Rest of Asia Pacific Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Hospital Acquired Infection Control Market Outlook, 2019-2032
7.1. Latin America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Heat Sterilization Equipment
7.1.1.1.1. Moist Heat Sterilization Equipment
7.1.1.1.2. Dry Heat Sterilization Equipment
7.1.1.2. Low-Temperature Sterilization Equipment
7.1.1.3. Radiation Sterilization Equipment
7.1.1.4. Disinfection Equipment
7.1.1.4.1. Disinfector
7.1.1.4.1.1. Disinfector
7.1.1.4.1.1.1. Washer Disinfector
7.1.1.4.1.1.2. Flusher Disinfector
7.1.1.4.2. Flusher Disinfector
7.1.1.5. Endoscopic Reprocessor Systems
7.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
7.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
7.1.1.6. Disinfectants
7.2. Latin America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Ambulatory Surgical Centres
7.2.1.3. Medical Institutions
7.2.1.4. Diagnostic Laboratories
7.2.1.5. Clinics
7.3. Latin America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Brazil Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.2. Brazil Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.3. Mexico Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.4. Mexico Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.5. Argentina Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.6. Argentina Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.7. Rest of Latin America Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.1.8. Rest of Latin America Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Hospital Acquired Infection Control Market Outlook, 2019-2032
8.1. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Heat Sterilization Equipment
8.1.1.1.1. Moist Heat Sterilization Equipment
8.1.1.1.2. Dry Heat Sterilization Equipment
8.1.1.2. Low-Temperature Sterilization Equipment
8.1.1.3. Radiation Sterilization Equipment
8.1.1.4. Disinfection Equipment
8.1.1.4.1. Disinfector
8.1.1.4.1.1. Disinfector
8.1.1.4.1.1.1. Washer Disinfector
8.1.1.4.1.1.2. Flusher Disinfector
8.1.1.4.2. Flusher Disinfector
8.1.1.5. Endoscopic Reprocessor Systems
8.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
8.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
8.1.1.6. Disinfectants
8.2. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Ambulatory Surgical Centres
8.2.1.3. Medical Institutions
8.2.1.4. Diagnostic Laboratories
8.2.1.5. Clinics
8.3. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. GCC Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.2. GCC Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.3. South Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.4. South Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.5. Egypt Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.6. Egypt Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.7. Nigeria Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.8. Nigeria Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.9. Rest of Middle East & Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.1.10. Rest of Middle East & Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Olympus Corporation
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Medivators Inc. (Cantel Medical Corp.)
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Getinge Group
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. STERIS Plc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Belimed AG (Metall Zug)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Steelco S.P.A.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Pfizer Inc.,
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. F. Hoffmann-La Roche Ltd,
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Merck & Co.,
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson),
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Abbott Laboratories
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Bayer AG
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. The 3M Company
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Cepheid Inc.
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. UVision360 Inc.
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us